Phuong N. Huynh

Array ( [id] => 1130046 [patent_doc_number] => 06787328 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-07 [patent_title] => 'Methods and compositions relating to CD39-like polypeptides and nucleic acids' [patent_app_type] => B1 [patent_app_number] => 09/905732 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 50 [patent_no_of_words] => 44106 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787328.pdf [firstpage_image] =>[orig_patent_app_number] => 09905732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1025173 [patent_doc_number] => 06884872 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-26 [patent_title] => 'Methods and compositions relating to CD39-like polypeptides and nucleic acids' [patent_app_type] => utility [patent_app_number] => 09/905589 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 49 [patent_no_of_words] => 33811 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884872.pdf [firstpage_image] =>[orig_patent_app_number] => 09905589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1089644 [patent_doc_number] => 06828423 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-07 [patent_title] => 'Methods and compositions relating to CD39-like polypeptides and nucleic acids' [patent_app_type] => B1 [patent_app_number] => 09/905743 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 49 [patent_no_of_words] => 44084 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828423.pdf [firstpage_image] =>[orig_patent_app_number] => 09905743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1136347 [patent_doc_number] => 06780410 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-24 [patent_title] => 'Methods and compositions relating to CD39-like polypeptides and nucleic acids' [patent_app_type] => B1 [patent_app_number] => 09/905744 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 49 [patent_no_of_words] => 44078 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780410.pdf [firstpage_image] =>[orig_patent_app_number] => 09905744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1162260 [patent_doc_number] => 06759214 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Methods and compositions relating to CD39-like polypeptides and nucleic acids' [patent_app_type] => B1 [patent_app_number] => 09/908510 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 49 [patent_no_of_words] => 44110 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759214.pdf [firstpage_image] =>[orig_patent_app_number] => 09908510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6129769 [patent_doc_number] => 20020076793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4' [patent_app_type] => new [patent_app_number] => 09/895263 [patent_app_country] => US [patent_app_date] => 2001-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9951 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076793.pdf [firstpage_image] =>[orig_patent_app_number] => 09895263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062906 [patent_doc_number] => 20020031513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals' [patent_app_type] => new [patent_app_number] => 09/886114 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18251 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031513.pdf [firstpage_image] =>[orig_patent_app_number] => 09886114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110432 [patent_doc_number] => 20020172678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'EG-VEGF nucleic acids and polypeptides and methods of use' [patent_app_type] => new [patent_app_number] => 09/886242 [patent_app_country] => US [patent_app_date] => 2001-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 43224 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172678.pdf [firstpage_image] =>[orig_patent_app_number] => 09886242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6079867 [patent_doc_number] => 20020081288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Superoxide dismutase-4' [patent_app_type] => new [patent_app_number] => 09/883985 [patent_app_country] => US [patent_app_date] => 2001-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8715 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081288.pdf [firstpage_image] =>[orig_patent_app_number] => 09883985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128428 [patent_doc_number] => 20020076420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Methods to block IgE binding to cell surface receptors of mast cells' [patent_app_type] => new [patent_app_number] => 09/882728 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6914 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076420.pdf [firstpage_image] =>[orig_patent_app_number] => 09882728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 686319 [patent_doc_number] => 07078034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => 'In vitro activated γ δ lymphocytes' [patent_app_type] => utility [patent_app_number] => 09/879398 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6382 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078034.pdf [firstpage_image] =>[orig_patent_app_number] => 09879398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 529630 [patent_doc_number] => 07179612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => 'Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality' [patent_app_type] => utility [patent_app_number] => 10/019087 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 50 [patent_no_of_words] => 12092 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179612.pdf [firstpage_image] =>[orig_patent_app_number] => 10019087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6324012 [patent_doc_number] => 20020197268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Allergen-containing milk for allergy treatment' [patent_app_type] => new [patent_app_number] => 09/877160 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5682 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197268.pdf [firstpage_image] =>[orig_patent_app_number] => 09877160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642686 [patent_doc_number] => 20030103984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Fusion proteins of biologically active peptides and antibodies' [patent_app_type] => new [patent_app_number] => 09/865281 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6022 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103984.pdf [firstpage_image] =>[orig_patent_app_number] => 09865281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6643085 [patent_doc_number] => 20030104013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound' [patent_app_type] => new [patent_app_number] => 09/867159 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4128 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104013.pdf [firstpage_image] =>[orig_patent_app_number] => 09867159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017619 [patent_doc_number] => 20020103345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Bispecific immunoglobulin-like antigen binding proteins and method of production' [patent_app_type] => new [patent_app_number] => 09/865198 [patent_app_country] => US [patent_app_date] => 2001-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15873 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103345.pdf [firstpage_image] =>[orig_patent_app_number] => 09865198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922924 [patent_doc_number] => 20020115601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Methods of increasing lean tissue mass using OB protein compositions' [patent_app_type] => new [patent_app_number] => 09/859768 [patent_app_country] => US [patent_app_date] => 2001-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10173 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 589 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115601.pdf [firstpage_image] =>[orig_patent_app_number] => 09859768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1212452 [patent_doc_number] => 06709840 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-23 [patent_title] => 'Anergy associated genes' [patent_app_type] => B1 [patent_app_number] => 09/854300 [patent_app_country] => US [patent_app_date] => 2001-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16744 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/709/06709840.pdf [firstpage_image] =>[orig_patent_app_number] => 09854300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014932 [patent_doc_number] => 20020102232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Compositions and methods for induction of active autoimmunity' [patent_app_type] => new [patent_app_number] => 09/852976 [patent_app_country] => US [patent_app_date] => 2001-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19486 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102232.pdf [firstpage_image] =>[orig_patent_app_number] => 09852976 [rel_patent_id] =>[rel_patent_doc_number] =>)